MUMBAI, India, Oct. 23, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2024....
Piramal Pharma Limited Announces Results for Q2 and H1 FY25
Seaking AlphaSeeking Alpha / Seaking Alpha 7 hours ago 1 Views
Comments